Literature DB >> 23184149

X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.

Thilo Herzfeld1, Dagmar Nolte, Maria Grznarova, Andrea Hofmann, Joachim L Schultze, Ulrich Müller.   

Abstract

X-chromosomal dystonia parkinsonism syndrome (XDP, 'lubag') is associated with sequence changes within the TAF1/DYT3 multiple transcript system. Although most sequence changes are intronic, one, disease-specific single-nucleotide change 3 (DSC3), is located within an exon (d4). Transcribed exon d4 occurs as part of multiple splice variants. These variants include exons d3 and d4 spliced to exons of TAF1, and an independent transcript composed of exons d2-d4. Location of DSC3 in exon d4 and utilization of this exon in multiple splice variants suggest an important role of DSC3 in the XDP pathogenesis. To test this hypothesis, we transfected neuroblastoma cells with four expression constructs, including exons d2-d4 [d2-d4/wild-type (wt) and d2-d4/DSC3] and d3-d4 (d3-d4/wt and d3-d4/DSC3). Expression profiling revealed a dramatic effect of DSC3 on overall gene expression. Three hundred and sixty-two genes differed between cells containing d2-d4/wt and d2-d4/DSC3. Annotation clustering revealed enrichment of genes related to vesicular transport, dopamine metabolism, synapse function, Ca(2+) metabolism and oxidative stress. Two hundred and eleven genes were differentially expressed in d3-d4/wt versus d3-d4/DSC3. Annotation clustering highlighted genes in signal transduction and cell-cell interaction. The data show an important role of physiologically occurring transcript d2-d4 in normal brain function. Interference with this role by DSC3 is a likely pathological mechanism in XDP. Disturbance of dopamine function and of Ca(2+) metabolism can explain abnormal movement; loss of protection against reactive oxygen species may account for the neurodegenerative changes in XDP. Although d3-d4 also affect genes potentially related to neurodegenerative processes, their physiologic role as splice variants of TAF1 awaits further exploration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184149     DOI: 10.1093/hmg/dds499

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Authors:  Rachel Underwood; Bing Wang; Christine Carico; Robert H Whitaker; William J Placzek; Talene A Yacoubian
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

2.  Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism.

Authors:  Toshitaka Kawarai; Paul Matthew D Pasco; Rosalia A Teleg; Masaki Kamada; Waka Sakai; Komei Shimozono; Makoto Mizuguchi; Daisy Tabuena; Antonio Orlacchio; Yuishin Izumi; Satoshi Goto; Lillian V Lee; Ryuji Kaji
Journal:  Neurogenetics       Date:  2013-02-23       Impact factor: 2.660

Review 3.  Neuron-specific alternative splicing of transcriptional machineries: Implications for neurodevelopmental disorders.

Authors:  Robert S Porter; Farris Jaamour; Shigeki Iwase
Journal:  Mol Cell Neurosci       Date:  2017-12-15       Impact factor: 4.314

4.  Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.

Authors:  Aloysius Domingo; David Amar; Karen Grütz; Lillian V Lee; Raymond Rosales; Norbert Brüggemann; Roland Dominic Jamora; Eva Cutiongco-Dela Paz; Arndt Rolfs; Dirk Dressler; Uwe Walter; Dimitri Krainc; Katja Lohmann; Ron Shamir; Christine Klein; Ana Westenberger
Journal:  Cell Mol Life Sci       Date:  2016-02-15       Impact factor: 9.261

5.  New insights into the genetics of X-linked dystonia-parkinsonism (XDP, DYT3).

Authors:  Aloysius Domingo; Ana Westenberger; Lillian V Lee; Ingrid Brænne; Tian Liu; Inga Vater; Raymond Rosales; Roland Dominic Jamora; Paul Matthew Pasco; Eva Maria Cutiongco-Dela Paz; Karen Freimann; Thomas Gpm Schmidt; Dirk Dressler; Frank J Kaiser; Lars Bertram; Jeanette Erdmann; Katja Lohmann; Christine Klein
Journal:  Eur J Hum Genet       Date:  2015-01-21       Impact factor: 4.246

6.  De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy?

Authors:  Alfonso Caro-Llopis; Monica Rosello; Carmen Orellana; Silvestre Oltra; Sandra Monfort; Sonia Mayo; Francisco Martinez
Journal:  Pediatr Res       Date:  2016-08-08       Impact factor: 3.756

Review 7.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

8.  Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses.

Authors:  Diego Iacono; Maria Geraci-Erck; Hui Peng; Marcie L Rabin; Roger Kurlan
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-05-13

9.  Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.

Authors:  Naoto Ito; William T Hendriks; Jyotsna Dhakal; Christine A Vaine; Christina Liu; David Shin; Kyle Shin; Noriko Wakabayashi-Ito; Marisela Dy; Trisha Multhaupt-Buell; Nutan Sharma; Xandra O Breakefield; D Cristopher Bragg
Journal:  Dis Model Mech       Date:  2016-01-14       Impact factor: 5.758

10.  TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations.

Authors:  Jason A O'Rawe; Yiyang Wu; Max J Dörfel; Alan F Rope; P Y Billie Au; Jillian S Parboosingh; Sungjin Moon; Maria Kousi; Konstantina Kosma; Christopher S Smith; Maria Tzetis; Jane L Schuette; Robert B Hufnagel; Carlos E Prada; Francisco Martinez; Carmen Orellana; Jonathan Crain; Alfonso Caro-Llopis; Silvestre Oltra; Sandra Monfort; Laura T Jiménez-Barrón; Jeffrey Swensen; Sara Ellingwood; Rosemarie Smith; Han Fang; Sandra Ospina; Sander Stegmann; Nicolette Den Hollander; David Mittelman; Gareth Highnam; Reid Robison; Edward Yang; Laurence Faivre; Agathe Roubertie; Jean-Baptiste Rivière; Kristin G Monaghan; Kai Wang; Erica E Davis; Nicholas Katsanis; Vera M Kalscheuer; Edith H Wang; Kay Metcalfe; Tjitske Kleefstra; A Micheil Innes; Sophia Kitsiou-Tzeli; Monica Rosello; Catherine E Keegan; Gholson J Lyon
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.